Search results
Gene-sequencing group Illumina sees $1.47 bn Q2 impairment charge linked to Grail
Investing.com via Yahoo Singapore Finance· 5 hours agoInvesting.com -- Gene-sequencing firm Illumina (NASDAQ:ILMN) said it would take goodwill impairment charge of $1.47 billion in its second quarter linked to its recently spun-off cancer diagnostic test manufacturer Grail (NASDAQ:GRAL).
Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2
Reuters via Yahoo Singapore Finance· 13 hours agoGene-sequencing equipment maker Illumina said it will likely recognize an additional impairment...
How the Royal Oak Became Audemars Piguet’s Hottest Watch
Robb Report via Yahoo Style Singapore· 19 hours agoThe Royal Oak has defined sports watch elegance since 1972, and in the past few years it has seen a...
MillerKnoll (MLKN) Q4 Earnings Beat Estimates, Net Sales Lag
Zacks via Yahoo Singapore Finance· 18 hours agoMillerKnoll's (MLKN) fourth-quarter fiscal 2024 results reflect the notable performance of the...